TABLE 1

Pharmacokinetic Parameters of 11C-SC-62807 in Wild-Type and Bcrp–/– Mice

Pharmacokinetic parameterWild-type miceBcrp–/– miceRatio of Bcrp–/– to wild-type
AUCblood,0–30 min (% dose × min/mL)42 ± 1893 ± 19*2.2 ± 1.1
AUCliver,0–30 min (% dose × min/mL)369 ± 85535 ± 761.5 ± 0.4
AUCkidney,0–30 min (% dose × min/mL)170 ± 361,119 ± 1266.6 ± 1.6
Kp,liver,AUC (mL/g of liver)8.8 ± 3.05.6 ± 0.80.64 ± 0.24
Kp,kidney,AUC (mL/g of kidney)4.0 ± 1.311.7 ± 2.3*2.9 ± 1.1
Xbile,0–30 min (% dose)48 ± 313 ± 20.28 ± 0.04
Xurine,0–30 min (% dose)26 ± 53.0 ± 1.70.11 ± 0.07
CLbile,blood,0–30 min (mL/min/kg)48 ± 195.1 ± 1.60.11 ± 0.05
CLrenal,blood,0–30 min (mL/min/kg)25 ± 81.2 ± 0.7*0.046 ± 0.033
CLint,bile,liver (mL/min/kg)4.5 ± 0.81.2 ± 0.1*0.26 ± 0.05
CLint,urine,kidney (mL/min/kg)13 ± 20.12 ± 0.07*0.0088 ± 0.0051
  • * Unpaired t test, P < 0.01.

  • Unpaired t test, P < 0.05.

  • Unpaired t test, P < 0.001.

  • Each value represents mean ± SD (n = 34). Statistically significant difference was observed for several pharmacokinetic parameters in Bcrp–/– mice, compared with wild-type.